Format

Send to

Choose Destination
See comment in PubMed Commons below
Int J Cardiovasc Imaging. 2011 Feb;27(2):271-87. doi: 10.1007/s10554-011-9796-3. Epub 2011 Mar 11.

Optical coherence tomography endpoints in stent clinical investigations: strut coverage.

Author information

1
Cardiovascular Research Core Laboratory, University Hospitals Case Medical Center, Cleveland, OH 44106-5038, USA.

Abstract

Late stent thrombosis (LST) and very LST (VLST) are infrequent complications after drug-eluting stent (DES) implantation, but they carry a significant risk for patients. Delayed healing, which may be represented by incomplete stent coverage, has been observed in necropsy vessel specimens treated with DES. As a result, in vivo assessment of stent coverage, as well as stent apposition using optical coherence tomography (OCT), have been recently used as surrogate safety endpoints in clinical trials testing DES platforms. By adopting strut coverage assessed by OCT, one can assess the safety profile of the new generation of DES in preregistration studies. This article focuses on stent strut coverage as a central predictor of late DES thrombosis from the histopathological point of view, discusses the limitations of the current imaging modalities and presents the technical characteristics of OCT for the detection of neointimal coverage after stent implantation. We also review the preclinical and clinical investigations using this novel imaging modality.

PMID:
21394615
PMCID:
PMC4459645
DOI:
10.1007/s10554-011-9796-3
[Indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Springer Icon for PubMed Central
    Loading ...
    Support Center